Confirming the Diagnosis: Scans and Trends
At a Glance
Nelson syndrome progression is assessed mainly by comparing dedicated thin-section pituitary MRI scans for a new or growing tumor. ACTH trends add context, but a single high result cannot diagnose growth and may sometimes reflect assay interference.
Diagnosing tumor growth after an adrenalectomy has moved away from looking for a single “magic number” in a blood test. In the past, doctors might have waited for a very high ACTH level or visible skin changes to make a diagnosis [1]. Today, international medical consensus defines Corticotroph Tumor Progression (CTP-BADX) primarily through what is seen on a brain scan [2].
The Gold Standard: Thin-Section MRI
The most important tool for monitoring your health is a dedicated thin-section pituitary MRI [2]. Standard brain MRIs take “slices” that may be too thick to see small changes in a tiny gland like the pituitary. Thin-section scans take much more detailed images, allowing specialized radiologists to spot growth that is only a few millimeters in size [3].
According to the latest international guidelines, the diagnosis is typically made if a thin-section MRI shows [2]:
- New Detection: A tumor appears where there wasn’t one visible before.
- Radiological Progression: An existing tumor has clearly grown since your last scan.
Because prior surgeries, scanner differences, and measurement error can mimic small growth, images should be compared directly using a consistent protocol and interpreted by an experienced neuroradiologist/endocrinologist. A borderline change may need confirmation rather than immediate labeling as progression. Because many people (up to 68% in some cohorts) have no physical symptoms when this growth begins, these scheduled scans are the only way to catch progression early [4].
Tracking the ACTH Trajectory
Your doctor will also regularly measure your ACTH (adrenocorticotropic hormone) levels. High ACTH is an expected result of lost cortisol feedback, so one single high result is rarely enough for a diagnosis. Instead, doctors look at the trajectory—the direction and speed at which your numbers are changing [5].
- The Trend Matters: A rapid rise in ACTH over several months is often more concerning than a high number that stays stable [5].
- Early Warning Signs: In some research, an ACTH increase of more than 116 pg/mL within the first year after surgery was associated with a higher risk that a tumor might be starting to grow, though there is no generally applicable ACTH number that diagnoses progression [3].
- Timing is Key: To get an accurate trend, your blood should be drawn consistently according to your endocrinologist’s plan. Never delay or skip a daily or emergency steroid replacement dose on your own for a blood test, as this can cause an adrenal crisis. Record your steroid dose and the time you took it [6][7].
When the Lab Results Don’t Match
Sometimes, your blood test might show a very high ACTH level, but your MRI looks perfectly clear and you feel fine. In these cases, your doctor may investigate assay interference [8].
Medical labs use “assays” (chemical tests) to measure hormones. Uncommonly, other proteins in your blood can interfere with these tests, causing a “false high” reading [9]. Common causes of interference include:
- Heterophilic Antibodies: These are “sticky” antibodies in your blood that can accidentally bind to the test chemicals, making it look like you have more ACTH than you actually do [8].
- Platform Differences: Different labs use different brands of testing equipment. A sample that looks “high” on one machine (like the Siemens Immulite) might look “normal” on another (like a CIS Bio assay) [10][11].
If your numbers seem suspiciously high but your scans are stable, your endocrinologist and the clinical laboratory will investigate collaboratively. They can ask the lab to perform a “dilution study” or use “blocking reagents” to see if interference is skewing the results, but symptoms or MRI findings must never be disregarded while waiting for a different assay [8][12].
Common questions in this guide
What type of MRI checks for tumor growth in Nelson syndrome?
Can one high ACTH result diagnose Nelson syndrome progression?
What does a rising ACTH level mean after adrenalectomy?
Why might ACTH be high when my MRI is normal?
How should I prepare for ACTH testing after adrenalectomy?
How do doctors confirm a small change on a pituitary MRI?
One line in your results can change your plan.
A borderline thin-section MRI change may need confirmation before your care team labels it as tumor progression. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Nelson syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Nelson's Syndrome: An Update.
Fountas A, Karavitaki N
Endocrinology and metabolism clinics of North America 2020; (49(3)):413-432 doi:10.1016/j.ecl.2020.05.004.
PMID: 32741480 - 2
Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.
Reincke M, Albani A, Assie G, et al.
European journal of endocrinology 2021; (184(3)):P1-P16.
PMID: 33444221 - 3
ACTH increment post total bilateral adrenalectomy for Cushing's disease: a consistent biosignature for predicting Nelson's syndrome.
Das L, Bhansali A, Pivonello R, et al.
Pituitary 2020; (23(5)):488-497 doi:10.1007/s11102-020-01047-x.
PMID: 32449103 - 4
Characterizing and predicting the Nelson-Salassa syndrome.
Graffeo CS, Perry A, Carlstrom LP, et al.
Journal of neurosurgery 2017; (127(6)):1277-1287.
PMID: 28084914 - 5
Corticotroph tumor progression speed after adrenalectomy.
Bessiène L, Moutel S, Lataud M, et al.
European journal of endocrinology 2022; (187(6)):797-807 doi:10.1530/EJE-22-0536.
PMID: 36206174 - 6
A prospective longitudinal study of Pasireotide in Nelson's syndrome.
Daniel E, Debono M, Caunt S, et al.
Pituitary 2018; (21(3)):247-255 doi:10.1007/s11102-017-0853-3.
PMID: 29313180 - 7
From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update.
Bessiène L, Villa C, Bertagna X, et al.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2024; (132(10)):581-590 doi:10.1055/a-2359-8649.
PMID: 38959959 - 8
Corticotropin hormone assay interference: A case series.
Donegan DM, Algeciras-Schimnich A, Hamidi O, et al.
Clinical biochemistry 2019; (63()):143-147 doi:10.1016/j.clinbiochem.2018.11.006.
PMID: 30423322 - 9
Heterophile Antibody to Adrenocorticotropin Hormone Interfering with the Investigation of Cushing's Syndrome.
Morton A, Dover T
Indian journal of clinical biochemistry : IJCB 2019; (34(2)):234-236 doi:10.1007/s12291-018-0770-x.
PMID: 31093000 - 10
A Pitfall of Falsely Elevated ACTH: A Case Report and Literature Review.
Yang YY, Kuo CC, Lin MH, et al.
Journal of investigative medicine high impact case reports 2022; (10()):23247096221103368 doi:10.1177/23247096221103368.
PMID: 35699218 - 11
Clinical Spectrum of Adrenal Cushing's Syndrome and the Caution for Interpretation of Adrenocorticotrophic Hormone: A Single-Center Experience.
Gosavi V, Lila A, Memon SS, et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2022; (54(2)):57-66 doi:10.1055/a-1735-3232.
PMID: 35130566 - 12
Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.
Yener S, Demir L, Demirpence M, et al.
Endocrine 2017; (56(2)):308-316 doi:10.1007/s12020-017-1268-7.
PMID: 28247312
This page explains how clinicians evaluate possible Nelson syndrome progression after adrenalectomy for informational purposes only and does not constitute medical advice. Your endocrinologist should interpret your MRI findings and ACTH results in the context of your care.